SLC45A2 and melanoma: Compared to other melanocytic proteins, such as MART-1 and PMEL, the expression of SLC45A2 in normal melanocytes was shown to be less than 2%, resulting in a significantly improved melanoma-to-melanocyte CTL killing index.